In the ever-evolving landscape of modern healthcare, technological advancements continue to revolutionize medical procedures. One such innovation that has gained significant traction is Automated Suturing Devices Market. These cutting-edge tools offer numerous benefits, from reducing surgical time and improving precision to enhancing patient outcomes. This blog explores the rapidly growing automated suturing devices market and its potential impact on the medical industry.
Traditional suturing techniques require skilled hands and steady concentration. However, with automated suturing devices, surgeons can benefit from improved dexterity and control. These devices come equipped with advanced features like adjustable tension, accurate needle placement, and automatic knotting, enabling faster and more efficient wound closure. This efficiency not only reduces operative time but also minimizes the risk of infection and promotes faster recovery for patients.
Get your PDF Sample Report with Latest Market Information @ https://www.futuremarketinsights.com/reports/sample/rep-gb-579
According to projections, the market for automated suturing devices will bring in US$ 3.02 billion in 2022 and US$ 6.2 billion by 2032. Between 2022 and 2032, the market for automated suturing devices is projected to expand at a CAGR of 7.46%. The rise in the incidence of chronic diseases and the preference for minimally invasive procedures (MIS) over conventional surgical methods can be attributed to the market’s expansion.
Automated suturing devices incorporate cutting-edge technologies, such as robotic assistance and computer-guided stitching, which lead to unparalleled precision during surgeries. The controlled stitching significantly reduces the risk of complications and wound dehiscence, thereby improving patient outcomes and reducing the need for follow-up procedures.
The automated suturing devices market has experienced exponential growth in recent years. The increasing number of surgeries, coupled with the rising demand for minimally invasive procedures, has fueled the adoption of these advanced tools across various healthcare settings. Moreover, manufacturers’ focus on product innovation and ergonomic designs further contributes to market expansion.
Key Takeaways from FMI’s Automated Suturing Devices Market Study:
- The automated suturing devices market in the U.S. will witness positive growth owing to rising prevalence of cardiovascular diseases and requirement for invasive procedures in the country.
- France will find lucrative opportunities during the forecast period as according to the Organization of Economic Cooperation and Development, approximately 148075 minimal invasive surgeries took place in France in 2018. The country also has presence of several manufacturers such as Guerbet, Sanofi, and others.
- Disposable automated suturing devices are expected to lead the product segment as they are cost-effective. Rising demand for laparoscopy and minimally invasive procedures are also encouraging demand for the same.
- Hospitals will exhibit high demand for automated suturing devices since they receive a higher footfall of patients on a daily basis.
Reach Out to Our Analyst For Your Queries @ https://www.futuremarketinsights.com/ask-question/rep-gb-579
“Several leading players are aiming for clearance from the United States Food and Drug Administration to launch advanced automated suturing devices. With focus on technological improvements on cards, the market is expected to gain momentum in the coming years,” says a FMI analyst.
Who is Winning?
Key players in the global automated suturing devices market are focusing on adopting inorganic strategies such as alliance, collaboration, partnerships, and merger and acquisitions to strengthen their position in the supply chain channels.
They are also emphasizing on launching new products and expanding their product portfolio. Key players operating in the global automated suturing devices market are Medtronic Plc., Boston Scientific, C. R. Bard, Inc., Apollo Endosurgery, EndoEvolution, LLC, LSI Solutions, Inc., and SuturTek Inc.
On March 3rd 2020, Origami Surgical launched StitchKit, a patented suture delivery and retrieval system. The U.S. Food and Drug Administration (FDA) approved 510k clearance for three novel types of sutures for the company’s StitchKit robotic surgery platform.
On November 2020, Healthium Medtech, one of India’s largest medical devices company, launched Trubarb, its latest innovation. This innovation is a knotless tissue closure device that reforms the suturing experience.
For More Report Customization, connect with us at @ https://www.futuremarketinsights.com/customization-available/rep-gb-579
On June 1st 2021, Anchora Medical, a Alon Medtech Venture’s company, announced closing of $4.5million financing led by HOYA Corporation and Tal Capital. The funds will be utilized for completing Anchora’s single use laparoscopic suturing devices.
Key Segments:
Product
- Reusable Automated Suturing Devices
- Disposable Automated Suturing Devices
Applications
- Minimally Invasive Surgeries
- Open Surgeries
- Trauma Cases
For In-Depth Competitive Analysis – Purchase this Report now at a discounted price @ https://www.futuremarketinsights.com/checkout/579
End Use
- Hospitals
- Clinics
- Ambulatory Surgical Centers
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube